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Objectives: Our objective was to assess the association between anxiety and risk of 
coronary heart disease (CHD).  
Background: In contrast to other negative emotions, such as depression, less research 
has focused on the association of anxiety with incident CHD.  
Methods: A meta-analysis of references derived from MEDLINE, EMBASE and 
PSYCINFO (1980- May 2009) was performed without language restrictions. 
Endpoints were cardiac death, myocardial infarction (MI) and cardiac events. The 
authors selected prospective studies of (non-psychiatric) cohorts of initially healthy 
persons in which anxiety was assessed at baseline.  
Results: Twenty studies reporting on incident CHD enclosed 249.846 persons with a 
mean follow-up period of 11.2 years. Anxious persons were at risk of CHD (hazard 
ratio (HR) random: 1.26; 95% confidence interval (CI): 1.15-1.38; p<0.0001) and 
cardiac death (HR: 1.48; 95% CI: 1.14-1.92; p=0.003), independent of demographic 
variables, biological risk factors and health behaviors. There was a nonsignificant 
trend for an association between anxiety and non-fatal MI (HR: 1.43; 95% CI: 0.85-
2.40; p=0.180). Subgroup analyses did not show any significant differences regarding 
study characteristics, with significant associations for different types of anxiety, short 
and long-term follow-up and both men and women.  
Conclusions: Anxiety appeared to be an independent risk factor for incident CHD 
and cardiac mortality. Future research should examine the association between 
anxiety and CHD with valid and reliable anxiety measures and focus on the 
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Research has demonstrated an association between psychological factors such as 
stress, and both the development of coronary heart disease (CHD) and CHD outcomes 
[1,2]. Most studies have focused on the role of depression, with several meta-analyses 
indicating that depression is an independent risk factor for the development of CHD in 
the general population [3], as well as a prognostic risk factor in CHD patients [4]. 
While evidence suggests that anxiety also has an adverse impact on prognosis in CHD 
patients independent of depression [5-8], the role of anxiety as an etiological risk 
factor is less clear. While several studies suggest that anxiety may contribute to the 
development of CHD in initially healthy individuals [9] and found an effect on 
cardiac death [10-12] or incident myocardial infarction (MI) [13,14], others have 
found no association [15,16].  
Meta-analytic research may help to resolve these inconsistencies but, to our 
knowledge, no recent meta-analysis has yet been conducted on the association 
between anxiety and incident heart disease. The present meta-analysis therefore 
focuses on the impact of anxiety on the development of CHD in initially healthy 
persons. The first objective of this study was to investigate the association of anxiety 
with incident CHD independent of traditional cardiovascular risk factors. The second 
objective was to examine whether the associations between anxiety and incident CHD 
were different for MI versus cardiac mortality as outcomes. 
 
Methods 
The aim was to assess the association between a comprehensive set of common 
anxiety constructs (including anxiety, panic, phobia, post-traumatic stress, and worry) 
and incident CHD. We identified all studies available by May 2009, on the 
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development of CHD in anxious versus non-anxious persons. Methods for systematic 
identification, appraisal, synthesis and statistical aggregation of information, and 
reporting of results were chosen according to predetermined methods [17,18].  
 
Literature search 
The electronic databases MEDLINE, EMBASE and PSYCINFO (1980- May 2009) 
were searched using the following terms: “(community or cohort or healthy persons or 
risk) and (anxiety or post traumatic stress disorder or tension or anxiety symptoms or 
anxiety disorder or panic or panic attacks or phobic anxiety or phobia or worry) and 
(mortality or coronary mortality or myocardial infarction or coronary heart disease or 
sudden cardiac death)”. There were no language restrictions and both published and 
unpublished data were included. In addition, reference lists of included studies and 
review articles were checked to identify additional studies meeting selection criteria. 
 
Selection 
Two independent raters (A.R. and J.D.) identified studies meeting the following pre 
specified inclusion criteria: 
  
1. Studies were prospective in nature, following a (non-psychiatric) cohort of initially 
healthy persons over time. 
2. At baseline, studies had to include at least one self-report or interview-based 
assessment of anxiety symptoms or anxiety disorder; e.g., post traumatic stress 
disorder, tension, worry, phobic anxiety, panic, or generalized anxiety disorder.  
3. Endpoints included cardiac mortality or MI. 




During the selection procedure, in case of disagreement between the two 
raters, the four investigators discussed the difference of opinion until consensus was 
reached. When study samples included healthy persons combined with a small 
number of heart disease patients, these studies were included when the original study 
adjusted for the presence of medical conditions [15,16,19-22]. Regarding multiple 
reports on the same dataset, only one paper was included based on the anxiety 
measure, study sample, endpoint, and follow-up period, preferring (in order of 
importance) general anxiety measured with a reliable and valid measure, multiple 
cardiac endpoints (e.g., cardiac mortality and MI), larger sample sizes, and longer 
follow-up periods. Regarding the different papers reporting on the Normative Aging 
Study, the study of Kubzansky et al. [23] was included because this study reported on 
general anxiety as measured with the Minnesota Multiphasic Personality Inventory 
(MMPI) and on non-fatal MI and cardiac mortality. We included both studies of 
Haines et al. [10,24], as they represented different outcomes. We retrieved the 
association between phobic anxiety and cardiac mortality from the later study (given 
the longer follow-up period) [24], and the association between phobic anxiety and MI 
from the earlier study [10]. If necessary, the corresponding authors of the eligible 
studies were asked to provide additional information.    
Information on sample size and characteristics (e.g. did the researchers include 
specific in-/exclusion criteria such as gender), anxiety assessment, endpoints, 
participation rate, percentage lost to follow-up, follow-up duration, bivariate and 
fully-adjusted relative risks and 95% confidence intervals (CI), and variables used in 
multivariable analysis was abstracted and evaluated. We did not weigh the 
contribution of each study to the meta-analysis on the basis of quality scoring for 
 7 
 
there are no validated measures of quality for observational studies and the use of 
subjective rating scales may lead to bias [25]. 
 
Endpoints 
We examined the association between anxiety and incident CHD. If a study reported 
on MI and cardiac mortality separately, we included cardiac mortality as endpoint 
[23,26]. Concerning the papers of Haines et al., we included their study reporting on 
cardiac mortality [24]. We focused on hard medical endpoints and, if possible, kept 
angina out of our analysis [23,27] because anxiety may be associated with the report 
of symptoms of chest pain without reflecting underlying CHD [27]. One included 
study reported on a broader endpoint, namely cardiovascular events (including cardiac 
death and non-fatal MI) [19]. We also examined the associations between anxiety and 
non-fatal MI and cardiac mortality (including sudden cardiac death and other cardiac 
death) separately.  
 
Quantitative data synthesis 
Data from all studies were pooled. We combined hazard ratios, relative risks and odds 
ratios from multivariable analyses. For one paper we had to recalculate the CI [22] 
because the log values for lower and upper limits were not symmetric. We suspected a 
relatively large heterogeneity in results given that the included studies differed in 
anxiety types, anxiety measures, and sample characteristics (e.g., gender). We 
therefore used the Random Effects Method to generate a summary estimate of effect 
estimates and tested the amount of heterogeneity with the Q test of homogeneity and 
the I² test, which indicates the proportion of total variance explained by heterogeneity.   
In one study the relative risk of anxiety predicting CHD was expressed relative to a 
standard deviation increase in anxiety score [28]. We calculated a new relative risk 
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and CI, based on the assumption of normal distribution, assuming that 20% of the 
sample experienced increased anxiety (mean anxiety prevalence of other included 
studies).  
If a study included various scales of the Crown Crisp index, e.g. Haines et al. 
[10,24], the phobic anxiety scale was selected because it was most representative of 
other studies using the Crown Crisp Index [11,26]. If the association between anxiety 
and CHD was assessed separately for men and women, we included that study twice 
with sample sizes according to the number of men and women in the study [22,28]. In 
the studies from Eaker et al. [28,29], the tension scale was used because it reflects 
psychological symptoms of anxiety whereas the anxiety scale mainly reflects 
physiological arousal [28] that may be confounded by underlying cardiac disease.  
We conducted a subgroup comparison between studies including all persons versus 
studies focusing on the contrast between high versus low anxiety subgroups. 
If study outcomes were heterogeneous based on the I
2
 test/Q test, the possible 
effects of anxiety type, follow-up period and study sample (healthy persons versus 
healthy and heart disease patients and men versus women) were studied. 
 Differences in effect estimates between the subgroups were assessed by 
comparing the pooled effect estimates using chi-squared analysis, comparing 
logarithms of these estimates. In order to evaluate the presence of publication bias, a 
funnel plot was constructed by plotting the effect measure against the inverse of its 
standard error. We used Egger’s test of the intercept, the classic fail-safe N and Duval 
and Tweedie’s Trim and Fill test to estimate the severity of publication bias. All 
analyses were performed with the program Comprehensive Meta-Analysis version 2. 
 
Additional information by personal communication 
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The author of one included study was contacted for further information and supplied 




A flow diagram of the literature search is shown in Figure 1. The agreement rates 
(Cohen’s kappa) for the 2 steps in the selection procedure were 0.81 and 0.94 
respectively, indicating very good consistency of judgment by raters [30]. Twenty-one 
studies, published between 1987 and 2009, met selection criteria of which the 
characteristics are shown in tables 1 and 2. Of these studies, 20 reported on incident 
CHD, 9 on cardiac mortality and 5 on non-fatal MI. 
 
Incident CHD 
Twenty studies that reported on incident CHD enclosed 249.846 persons. Mean 
follow-up period was 11.2 years, with follow-up periods ranging from 2.0 to 20.9 
years. The mean age at baseline assessment ranged from 38 to 72 years. Eleven 
analyses reported on males, 7 on females and 4 on a combined sample of males and 
females. Fourteen analyses (70%) showed a statistically significant univariable 
association between anxiety and CHD and 10 (50%) were significant in multivariable 
analyses (table 2). 
The pooled HR for incident CHD (favoring cardiac death in case of multiple 
endpoints) was 1.26 (95% CI: 1.15-1.38; p<0.0001) when pooling multivariable and 
bivariate HRs, in case no multivariable HR was reported in the original study [27,33] 




Cardiac mortality and MI 
Nine of the 21 included studies focused on cardiac mortality as a separate endpoint. 
Five studies found a significant association between anxiety and cardiac mortality 
[11,21,26,34,35], of which 3 remained significant in multivariable analyses 
[11,34,35]. The pooled multivariable HR for cardiac mortality was 1.48 (95% CI: 
1.14-1.92; p=0.003). The heterogeneity was lower than for incident CHD (Q= 17.61; 
p= 0.024; I²= 54.57). 
Five studies focused on non-fatal MI as a separate endpoint. Two studies 
found a significant association between general anxiety and MI [23,33], although one 
did not adjust for confounders [33]. The pooled HR for non-fatal MI was 1.43 (95% 
CI: 0.85-2.40; p=0.180). When excluding the paper that did not adjust for confounders 
[33], the HR decreased to 1.23 (95% CI: 0.74-2.05; p=0.416). There was no 
significant difference between the impact of anxiety on cardiac death versus non-fatal 
MI (p=0.91).  
 
Subgroup analyses 
Studies which included all persons in their analyses had a smaller pooled HR (1.19; 
95% CI: 1.07-1.33) in comparison with studies focusing on the contrast between high 
versus low anxiety subgroups (HR: 1.39; 95% CI: 1.16-1.66), but this difference was 
not statistically significant (p=0.15). There were no further differences for study 
sample, anxiety type and follow-up period. 
 A funnel plot of selected studies on the primary outcome suggested the 
presence of publication bias. Egger’s test showed a significant asymmetry (p<0.0001). 
The Fail-Safe N shows that another 389 null-studies are needed in order for the p-
value to exceed 0.05. According to the Trim and Fill test, the association between 
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anxiety and CHD remains significant after imputing possible missing studies (HR: 
1.16; 95% CI: 1.06-1.28) (Figure 3). 
 
Discussion 
This is the first meta-analysis focusing on the association of anxiety with the 
incidence of CHD in initially healthy individuals. The results show an association 
between anxiety and incident CHD with a 26% increase in risk. Anxiety was also 
specifically associated with cardiac mortality, with anxious persons having a 48% 
increased risk of cardiac death. There was a trend for an association between anxiety 
and incident non-fatal MI, but this association was based on only 5 studies. Subgroup 
analyses did not show any significant differences regarding study characteristics with 
significant associations for different types of anxiety, short and long-term follow-up 
and both men and women. Secondary analyses in the original studies, excluding heart 
disease patients at baseline, did also not affect the results [19,20].  
Recently published studies using large databases demonstrated a significant 
association between anxiety and MI [36] and panic disorder and CHD [37,38].  
Strength of this meta-analysis is the adjustment for covariates in most of the 
individual studies that were included. Only 2 studies did not adjust for covariates 
[27,33], of which one reported a significant association between anxiety and MI [33]. 
All other studies adjusted for a variety of demographic variables, biological risk 
factors and health behaviors. After adjustment for these variables, the HRs decreased, 
but still remained significant.  
 It is important to compare the strength of the association between anxiety and 
incident CHD with other psychological constructs. A recent meta-analysis showed 
that depression was associated with a 46% increased risk of cardiovascular disease 
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[39], and the impact of depression on cardiac death (55% increased risk) was 
comparable to the impact of anxiety found in the present meta-analysis. Five studies 
on anxiety and CHD adjusted for depression in their analyses [20,23,34,40,41], and 
four associations remained significant [20,23,34,40]. In a study of Philips et al., 
subjects with both generalized anxiety disorder and major depressive disorder were at 
greatest risk of subsequent cardiac death, suggesting that anxiety and depression may 
also interact synergistically to affect CHD [21]. Anxiety and depression have a 
moderate to strong correlation and it is possible that anxiety and depression are both 
part of a larger and more stable psychological factor influencing heart disease, like 
negative affectivity [42,43]. A recent meta-analysis focusing on the association of 
anger and hostility with CHD found a 19% increased risk, but (a) this association was 
no longer significant after adjusting for possible behavioral covariates [44] and (b) the 
association with CHD mortality was not significant [44]. This difference in anxiety 
and anger as potential predictors of cardiac death is of interest, and calls for 
confirmation in future research. 
There are several potential mechanisms that may help to explain the adverse 
association between anxiety and CHD. Anxiety has been associated with progression 
of atherosclerosis [45], decreased heart rate variability [46] and risk of ventricular 
arrhythmias [47,48]. Research supports the risk of arrhythmias particularly in the case 
of phobic anxiety, with studies showing an association between phobic anxiety and 
sudden cardiac death, but not with non-fatal MI [11,26]. More research is needed 
focusing on these possible mechanisms and the impact on different outcomes, 
particularly MI versus (sudden) cardiac death. Furthermore, anxiety is related to an 
unhealthy lifestyle in patients at risk of CHD [49]. In the present meta-analysis, 
unhealthy lifestyles (e.g. physical inactivity, increased body mass index and smoking) 
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were included as covariates, but they may also mediate the relationship between 
anxiety and CHD. This might indicate that the association between anxiety and CHD 
might be larger than reported here.  
Anxiety can be treated effectively with cognitive behavior therapy and 
medications, e.g. benzodiazepines and selective serotonin reuptake inhibitors [50]. 
Unfortunately, many patients do not receive adequate treatment [50]. Besides the 
impact of anxiety on disability and decreased quality of life, clinicians should be 
aware of the risk of anxiety associated with incident heart disease. Future research 
needs to investigate whether the treatment of anxiety has a significant beneficial effect 
on the incidence or course of cardiac disease [51]. 
 The results need to be considered in light of the study limitations. One 
important limitation in conducting a meta-analysis is the inevitability of combining 
data from studies that are not equally designed. Study samples were heterogeneous 
regarding age and gender and follow-up duration differed substantially across studies. 
Further, different anxiety measures were included, some of which were not 
extensively validated. As a result, the heterogeneity in our results is substantial. Also, 
only one included paper focused on an anxiety disorder, namely generalized anxiety 
disorder [21]. It is important that studies use a valid and reliable anxiety measure and 
more research is needed to the association of anxiety disorders with heart disease 
development. However, the finding of an association between anxiety and CHD was 
quite consistent across studies. Also, studies reporting on the Normative Aging Study 
showed comparable results for different anxiety types, such as post traumatic stress 
disorder [52] and worry [13], suggesting that a broad variety of anxiety symptoms 
influence incidence of CHD. Future research should focus on the specific aspects of 
anxiety that contribute to cardiac outcomes. Further, almost all studies were 
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conducted in Western populations which might limit the generalization of the 
findings. Another limitation concerns the proneness of meta-analyses to publication 
bias. We found an indication for publication bias, suggesting that the association 
between anxiety and CHD might be smaller than reported here. However, after 
adjusting for this possible bias the results still show a reliable association of anxiety 
with CHD.   
 
In summary, anxiety was found to be an independent risk factor for the incidence of 
CHD and cardiac mortality in initially healthy individuals. The strength of this 
association appeared to be somewhat lower compared to the effect of depression but 
clearly higher than that of anger. Future research should examine the relationship 
between anxiety and CHD with valid and reliable anxiety measures, and needs to 
focus on the mechanisms through which anxiety may affect the development and 
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Figure 1  
Flow-chart of literature search 
* Both reports of Haines et al. [10,24] were included; one with cardiac death [24] and 
one with non-fatal MI [10] as endpoint. CHD= coronary heart disease; MI= 
myocardial infarction. 
 
Figure 2  
Anxiety and risk of incident coronary heart disease 
 
Figure 3 

























1. Endpoints do not include cardiac 
mortality or MI                 n=11 
2. No baseline anxiety assessment n=8
3. No original data n=1
4. No prospective design n=2
5. age  >75 n=2
6. No control for medical 
conditions at baseline n=6
7. No cohort of (non-psychiatric) 
persons n=4
Eligibility of 




























Figure 2  
Study name Statistics for each study Hazard ratio and 95% CI
Hazard Lower Upper 
ratio limit limit Z-Value p-Value
Philips, 2009 1,840 0,981 3,452 1,899 0,058
Kubzanksy, 2009 3,460 1,348 8,884 2,580 0,010
Einvik, 2009 3,230 1,261 8,275 2,443 0,015
Denollet, 2008 2,770 1,168 6,569 2,313 0,021
Mykletun, 2007 0,890 0,676 1,171 -0,832 0,405
Smoller, 2007 4,200 1,763 10,006 3,240 0,001
Gafarov, 2007 2,700 1,273 5,725 2,590 0,010
Kubzansky, 2006 2,110 0,784 5,681 1,478 0,140
Thurston, 2006 1,380 1,149 1,658 3,440 0,001
Boyle, 2006 1,150 1,054 1,255 3,142 0,002
Albert, 2005 1,180 0,881 1,581 1,109 0,268
Eaker, 2005 men 1,040 1,006 1,075 2,320 0,020
Eaker, 2005 women 0,998 0,951 1,047 -0,082 0,935
Nicholson, 2005 1,280 0,759 2,158 0,926 0,354
Weitoft, 2005 men 1,490 1,142 1,944 2,940 0,003
Weitoft, 2005 women 1,040 0,748 1,446 0,233 0,816
Yasuda, 2002 1,840 0,763 4,437 1,358 0,175
Haines, 2001 1,290 0,711 2,342 0,837 0,403
Kawachi 1994 1,240 0,729 2,108 0,794 0,427
Vogt, 1994 1,180 0,852 1,634 0,996 0,319
Eaker, 1992 2,900 1,268 6,633 2,522 0,012
Rosengren, 1991 1,500 1,192 1,887 3,459 0,001
1,260 1,149 1,382 4,915 0,000
0,1 0,2 0,5 1 2 5 10















Heterogeneity Q= 81.23; p<0.0001; I²= 74,15           
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Figure 3  



































Table 1 Overview of selected studies investigating the association of anxiety with incident CHD 
 












Instrument Anxiety type FU 
(yr)  
Endpoints 
Phillips, 2009 (21) 4256 38 100 USA, 1986  69 0 DIS Generalized anxiety disorder 14.6 Cardiac mortality 
Kubzanksy, 2009 (38)  1059 44 0 USA, 1982 NA 23.6 NIMH DIS PTSD symptoms  14.0 Cardiac events 
*
 
Einvik, 2009 (19) 433  NA 
 
100 Norway, 1997 72 0 HADS-A General  3.0 Cardiovascular events † 
Denollet, 2008 (34) 5073 50 
 





10.0 Cardiac mortality 
Mykletun, 2007 (15)  61349 48 
 
NA Norway, 1995 66 NA HADS-A General  4.4  Cardiac mortality 
Smoller, 2007 (20) 3369 66 
 
0 USA, 1997 NA 0.03 Questionnaire based on 
DSM-IV 
 
Panic attacks 5.3  Cardiac events ‡ 
Gafarov, 2007 (33) 2149 NA 
 
100 Russia, 1984 NA NA STAI General 20.0 MI 
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Kubzansky, 2006 (23)  1306 61  
 
100 USA, 1986 82.4 NA MMPI-2 
Anxiety subscale 
 
General  10.9  Non-fatal MI and  
cardiac mortality 
Thurston, 2006  (31) 6265 NA 
 





Boyle, 2006 (39)  2105 47 100 USA, 1985 NA 3.0 MMPI-2 General  15.0 IHD 
Albert, 2005 (26) 72359 54 
 
0 USA, 1988  NA 2.0 CCI 
Phobia index 
 
Phobic 12.0 Non-fatal MI and 
cardiac mortality 
Eaker, 2005 (28) 3682 49 
 
48 USA, 1984  
 
NA <5 Tension and Symptoms of 
Anxiety Scales 
 
General  10.0 Cardiac events || 
Nicholson, 2005 (27)  5449 NA 
 
100 UK, 1985 74 NA GHQ-30 
Anxiety subscale 
 
General  6.8 Cardiac events  ‡ 
Ringbäck Weitoft, 2005 
(22)  
34511 43 50 Sweden, 1980 79-86 NA Single question General  5.0  IHD 
Yasuda, 2002 (16)  817 72 39 Japan, 1991 92 2.8 GHQ-30 
Anxiety subscale 
 
General  7.5 Cardiac mortality 




100 UK, 1972 80 NA CCI 
Phobia index 




Kawachi, 1994 (11)  33999 NA 
 
100 USA, 1986 NA 4.0 CCI 
Phobia index 
 
Phobic 2.0 Non-fatal MI and 
cardiac mortality 
Vogt, 1994 (32) 2573 NA 
 
46 USA, 1970 92 0 Bradburn Worries Index Worry 15.0 IHD 
Eaker, 1992 (29) 749 NA 
 
0 USA, 1965  NA NA Tension and Symptoms of 
Anxiety Scales 
 
General 20.0 Cardiac events  ‡ 
Rosengren, 1991 (35) 6935 NA 100 Sweden, 1970 76 NA Single question General 11.8 Cardiac events  ‡ 
Haines, 1987 (10) 1342 NA 
 
100 UK, 1972 80 2.8 CCI 
Phobia index 
Phobic  6.7  Non-fatal MI 
 
CCI= Crown-Crisp Index; DIS= Diagnostic Interview Schedule; DSM= Diagnostic Statistical Manual; EDS= Edinburgh Depression Scale; GHQ= General Health Questionnaire; GWB-A= General Well-Being 
Schedule anxiety subscale; HADS-A= Hospital Anxiety and Depression Scale, anxiety subscale; IHD= ischemic heart disease; MI= myocardial infarction; MMPI= Minnesota Multiphasic Personality Inventory; NA= 
not available; PTSD= Post traumatic stress disorder; STAI= Stait Trait Anxiety Index.  
 
* = angina pectoris, non-fatal MI, fatal MI and other cardiac death 
† = cardiac death, non-fatal MI, percuataneous coronary intervention, CABG, cerebral stroke, surgery on abdominal aortic aneurysm and revascularization in peripheral arterial disease 
‡ = non-fatal MI and cardiac death 
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§ = MI, other acute and subacute ischemic heart disease, other forms of chronic ischemic heart disease 
|| = non-fatal MI, coronary insufficiency and cardiac death 
 30 
 
Table 2 Overview of bivariate and multivariable associations of anxiety with incident CHD 




Phillips, 2009 (21)  Age 2.89 (1.59-5.23) Age, place of service, ethnicity, marital status, smoking habit, alcohol consumption, IQ at enlistment, 
household income in midlife, BMI, total cholesterol, SBP, blood glucose, and somatic illness. 
1.84 (0.98-3.45) 
Kubzanksy, 2009 (38) Age 3.21 (1.29-7.98) Age, race/ethnicity, smoking status, history of high blood pressure, history of diabetes, alcohol use, education, 
income.  
3.46 (1.35-8.90) 
Einvik, 2009 (19) - 3.17 (1.28-7.82) Age, previous cardiovascular disease, current smoking, level of serum glucose, diabetes, SBP, LDL-
cholesterol, alcohol use, BMI, treatment modality.  
3.23 (1.26-8.27)  
*
 
Denollet, 2008 (34) Age 2.74 (1.15-6.49) Age, education, living alone, hormone intake, smoking, alcohol, physical activity, BMI, hypertension, diabetes, 
depressive symptoms. 
2.77 (1.17-6.58) 
Mykletun, 2007 (15)  Age and gender 1.10 (0.84-1.43) Age, gender, somatic symptoms/diagnoses, physical impairment, health-related behavior (smoking, alcohol 
problems, physical activity) educational level and SES, physical measurement (BMI, DBP, total cholesterol 
level). 
0.89 (0.67-1.16) 
Smoller, 2007 (20) Age, race, 
income 
1.92 (1.20-3.07) Age, race, income, BMI, alcohol, hormone use, high cholesterol level requiring medication, history of diabetes 
mellitus treatment, smoking, depression, history of atrial fibrillation, hypertension status, moderate to strenuous 
activity for longer than 20 minutes 3 or more times a week, and history of MI, CABG, PTCA, or stroke. 
4.20 (1.76-9.99) 
Gafarov, 2007 (33) 
 
- 2.70 (1.27-5.71) “ “ 
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Kubzansky, 2006 (23)  Age 2.11 (0.8-5.6) Age, BMI, smoking status, SBP and DBP, serum cholesterol, family history of CHD, alcohol use, education. 2.11 (0.8-5.8) 
 
Thurston, 2006 (31) Age and gender 1.56 (1.31-1.86) 
 
Age, gender, marital status, race/ethnicity, smoking status, aerobic exercise, alcohol use, SBP, DBP, BMI, 
cholesterol, hypertension, diabetes status. 
1.38 (1.15-1.66) 
 
Boyle, 2006 (39) Age 1.18 (1.08-1.29) Age, total cholesterol, smoking status, hypertensive status, diabetes status, high density lipoprotein and BMI. 1.15 (1.05-1.25) 
 
Albert, 2005 (26) Age 1.55 (1.16-2.08) Age, smoking status, BMI, alcohol intake, menopausal status and hormone use, parental history of MI, physical 
activity, aspirin use, valium use, history of hypertension, hypercholesterolemia and diabetes.  
1.18 (0.88-1.58) 
 




Age, SBP, BMI, current cigarette smoking, diabetes, and total cholesterol/high-density cholesterol. 
1.04 (1.01-1.08)  † 
 
Eaker, 2005 (28) 
women 
- NA Age, SBP, BMI, current cigarette smoking, diabetes, and total cholesterol/high-density cholesterol. 1.00 (0.95-1.05)  † 
Nicholson, 2005 (27) 
 
Age 1.28 (0.76-2.16) “ “ 






Age, smoking, longstanding illness, education. 1,49 (1,14-1,94) 
 
Ringbäck Weitoft, 2005 (22)  
women 
Age 1.28 (0.94-1.74) 
 
Age, smoking, longstanding illness, education. 1.04 (0.75-1.45) 
 








Kawachi,  1994  (11) Age 1.40 (0.83-2.37) Age, smoking, alcohol, BMI, history of hypertension, diabetes mellitus, hypercholesterolemia, parental history 
of MI before the age of 60 years, physical activity. 
1.24 (0.73-2.11) 
Vogt, 1994 (32) - 2.34 (1.72-3.20) Age, gender, self-reported health status, self-reported social class, cigarette smoking status, duration of health 
plan membership.  
1.18 (0.85-1.63) 
Eaker, 1992 (29) NA NA Age, SBP, ratio of the serum total cholesterol to high-density lipoprotein cholesterol, diabetes, cigarette 
smoking and BMI. 
2.9 (1.3-6.8) 
Rosengren, 1991 (35) - 1.6 (1.3-2.0) Age, SBP, serum cholesterol, smoking, BMI, diabetes, family history of MI, occupational class, marital state, 
leisure time physical activity, registration for alcohol abuse.  
1.5 (1.2-1.9) 
Haines, 1987 (10) - NA Age, smoking habit, social class, shift (night or day), SBP, fibrinogen, cholesterol, factor VII activity. 1.26 (0.62-2.54) 
 
BMI= body mass index; CABG= coronary artery bypass graft; CHD= coronary heart disease; DBP= diastolic blood pressure; MI= myocardial infarction; NA= not available; PTCA= percutaneous transluminal 
coronary angioplasty; SBP= systolic blood pressure; SES= socioeconomic status. 
 
Bolded numbers are statistically significant 
 
*
 = HR received from author 
† = based on own calculations 
 
 
